SunOpta (NASDAQ:STKL) Stock Rating Lowered by StockNews.com

StockNews.com cut shares of SunOpta (NASDAQ:STKL) (TSE:SOY) from a hold rating to a sell rating in a research note issued to investors on Thursday.

SunOpta Price Performance

Shares of STKL stock opened at $6.67 on Thursday. The firm’s 50-day moving average is $5.84 and its two-hundred day moving average is $5.93. The company has a market capitalization of $795.99 million, a PE ratio of -4.39 and a beta of 1.82. The company has a debt-to-equity ratio of 1.67, a current ratio of 1.27 and a quick ratio of 0.61. SunOpta has a 12 month low of $2.79 and a 12 month high of $7.59.

SunOpta (NASDAQ:STKL) (TSE:SOY) last issued its quarterly earnings data on Wednesday, August 7th. The company reported $0.02 EPS for the quarter, topping the consensus estimate of $0.01 by $0.01. SunOpta had a negative net margin of 23.23% and a positive return on equity of 6.51%. The firm had revenue of $171.00 million for the quarter, compared to analyst estimates of $159.95 million. During the same period in the prior year, the business posted ($0.03) EPS. The business’s revenue for the quarter was down 17.7% compared to the same quarter last year. Analysts predict that SunOpta will post 0.14 earnings per share for the current year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently added to or reduced their stakes in STKL. Principal Financial Group Inc. increased its holdings in shares of SunOpta by 18.2% in the 1st quarter. Principal Financial Group Inc. now owns 12,425 shares of the company’s stock valued at $85,000 after acquiring an additional 1,917 shares during the last quarter. Mackenzie Financial Corp increased its stake in SunOpta by 0.9% in the second quarter. Mackenzie Financial Corp now owns 254,678 shares of the company’s stock valued at $1,370,000 after purchasing an additional 2,155 shares during the last quarter. Price T Rowe Associates Inc. MD raised its holdings in SunOpta by 13.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 26,913 shares of the company’s stock worth $185,000 after purchasing an additional 3,171 shares in the last quarter. The Manufacturers Life Insurance Company lifted its position in shares of SunOpta by 10.5% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 36,958 shares of the company’s stock worth $200,000 after buying an additional 3,521 shares during the last quarter. Finally, Epiq Partners LLC boosted its holdings in shares of SunOpta by 1.3% in the 1st quarter. Epiq Partners LLC now owns 295,455 shares of the company’s stock valued at $2,030,000 after buying an additional 3,750 shares in the last quarter. Institutional investors and hedge funds own 85.39% of the company’s stock.

SunOpta Company Profile

SunOpta Inc engages in manufacture and sale of plant-based and fruit-based food and beverage products in the United States, Canada, and internationally. The company provides plant-based beverages utilizing oat, almond, soy, coconut, rice, hemp, and other bases under the Dream and West Life brands; oat-based creamers under the SOWN brand; ready-to-drink protein shakes; and nut, grain, seed, and legume based beverages; packaged teas and concentrates; and meat and vegetable broths and stocks.